Product sales for the three months ended September 30, 2024 was $597,677 compared to $3,631 in the three months ended ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to ...

A soup mix recall issued this month has been updated by the U.S. Food and Drug Administration (FDA) as a Class I risk, the ...

Bard PowerPorts are implantable medical devices designed to streamline the delivery of medications. The devices are put under ...

The seafood salad may be of particular risk to those customers who have an allergy or severe sensitivity to soy, the FDA has ...

AdvaMed, the world’s largest medical technology association representing device, diagnostics and digital technology companies, released a white ...

Trump’s HHS pick is expected to work to eliminate processed foods from school lunches and push for the removal of dyes from ...

FDA Releases Guidance for Voluntary Qualified Importer Program - The U.S. Food and Drug Administration (FDA) has released ...

November has been an active month for food recalls leading up to one of the biggest eating holidays of the year: Thanksgiving ...

Amylyx is progressing promising treatments for Wolfram Syndrome and Progressive Supranuclear Palsy with potential phase 3 trials. Learn more on AMLX stock here.

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...